Do you need a Washington, DC Risperdal lawyer? Contact one of our Washington, DC Risperdal lawyers now.
Home : Unsafe Drugs : Risperdal : MSN Newsfeeds
Risperdal - MSN Newsfeeds
- Street.Com - On Thursday the company said it received an approvable letter from the Food and Drug Administration for schizophrenia drug Risperdal for adolescents. The letter didn't call for additional study data, just a bit of tinkering with the label, according ...
- StreetInsider.com - FDA Issues Approvable Letter For RISPERDAL - DJ Opexa Therapeutics (OPXA) Reports Positive Top-line Data in Phase I/II Extension ... Novartis Consumer Health (NYSE: NVS ) announced that the U.S. Food and Drug Administration (FDA) has given approval of ...
- Medical News Today - Elderly Patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL(R) (risperidone) is not approved for the treatment of patients with Dementia-Related Psychosis ...
- Times Online - Johnson & Johnson , the American pharmaceuticals group, said that US regulators have given conditional approval for Risperdal, its schizophrenia treatment. Industrials Up 1.9% Corus , the Anglo-Dutch steel maker owned by India’s Tata Steel, will ...
- United Press International - TITUSVILLE, N.J., June 21 (UPI) -- U.S. drug maker Johnson & Johnson said Thursday it is approved to market schizophrenia drug Risperdal in younger patients. The Food and Drug Administration sent an approvable letter to the company for expanded use ...
- Genetic Engineering News - Johnson & Johnson Pharmaceutical Research & Development (J&JPRD) received an approvable letter regarding two sNDAs for Risperdal®. The sNDAs are for the treatment of schizophrenia in adolescents between 13-17 years and for the short-term treatment ...
- San Diego Union-Tribune - NEW YORK – Johnson & Johnson Thursday said U.S. regulators have given conditional approval for use of its drug Risperdal as a treatment for adolescents with schizophrenia and children and adolescents in the manic phase of bipolar disorder. The ...
- Forbes - Johnson & Johnson said Thursday the Food and Drug Administration sent the company an approvable letter, asking for more information about the company's schizophrenia treatment Risperdal. The company did not specify what the FDA is specifically ...
- Morris County Daily Record - U.S. regulators delayed approving Johnson & Johnson's Risperdal drug to treat schizophrenia and bipolar disorder in adolescents. The Food and Drug Administration didn't request new studies in its approvable letter to the company, New Brunswick, New ...
- Phramalive.com - Food and Drug Administration (FDA) regarding two supplemental New Drug Applications (sNDA) for RISPERDAL(R) (risperidone), filed on Dec. 21, 2006. The sNDAs are for the treatment of schizophrenia in adolescents ages 13-17 years and for the short-term ...
- Phramalive.com - Leading products include Concerta(R) (ADHD), Durogesic(R) (pain management), Eprex(R) (anemia), Pariet(R) (gastroenterology), Topamax(R) (epilepsy, migraine prevention), Reminyl(R) (Alzheimer's disease), Risperdal(R) (schizophrenia, bipolar disorders ...
- MSN MoneyCentral - The group of medications known as atypical antipsychotics, including olanzapine, risperidone, clozapine and quetiapine, are widely used to treat schizophrenia and bipolar disorder. All medications in this group are associated with treatment ...
- Mid-Hudson News Network - ... many controlled substances, such as morphine, valium and steroids, are legal for medicinal use but illegal on the open market. “It’s hypocritical to forbid physicians to prescribe marijuana while permitting them to use morphine and risperidone ...
- Forbes - RISPERDAL(R) CONSTA(R) ((risperidone) long-acting injection), the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson ...
- Minneapolis Star Tribune - They include Paxil, Vioxx and Risperdal, the drug referred to in your editorial. There is a website, PhRMA, where drug companies publish the results of clinical trials on a voluntary basis. The drug companies refer to this website as a solution to ...
- Motley Fool - The long-lasting version of Johnson & Johnson 's (NYSE: JNJ ) Risperdal Consta that Alkermes developed had annual sales in excess of $900 million for the last fiscal year. For fiscal 2008 Risperdal Consta is expected to bring in around $100 million in ...
- Motley Fool - Its pharma sales could come under pressure due to all of the negativity surrounding its second-best seller, Procrit. The company's top drug, Risperdal Consta, will lose patent protection next year, opening the door for generic competitors. Together ...
- HealthCentral.com - RISPERDAL ( risperidone) s a psychotropic agent belonging to the chemical class of benzisoxazole derivatives. The chemical designation is 3-[ 2-[ 4-( 6-fluoro-1,2-benzisoxazol-3-yl) -1-piperidinyl ] ethyl ] -6,7,8,9-tetrahydro-2-methyl-4H-pyrido [ 1 ...
- HealthScout - Food and Drug Administration warned doctors about atypical antipsychotics, specifically olanzapine ( Zyprexa ), aripiprazole ( Abilify ), risperidone ( Risperdal ), and quetiapine ( Seroquel ). Fifteen of 17 studies of elderly patients with dementia -- which ...
- Forbes - RISPERDAL(R) CONSTA(R) ((risperidone) long-acting injection), the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag (Janssen), a wholly owned division of Johnson ...
Do you need a Washington, DC Risperdal lawyer? Contact one of our Washington, DC Risperdal lawyers now.
Pages: 1 2 3 4 5 6 ... Next
